BHIVA Satellite Symposium at the 9th IAS Conference on HIV Science (IAS 2017)

BHIVA Satellite Symposium at the 9th IAS Conference on HIV Science (IAS 2017) Tougher Times: Adapting to Increasing Demand with Declining Resources

Overview

The British HIV Association (BHIVA) held a Satellite Symposium on Monday 24 July 2017 at the 9th IAS Conference on HIV Science (IAS 2017).  It covered the current challenges facing the UK in terms of HIV prevention, care and lessons learned. It reviewed the potential efficiencies available through use of generics and simpler drug regimens including dual-therapy. The increasingly important role of the third sector and peer support, in a climate of ever-declining public health spending was also discussed. The session also reviewed the simplification of HIV monitoring including cessation of CD4 monitoring.

Presentations

Introduction by the Chairs
Chloe Orkin, Barts Health NHS Trust, United Kingdom
Jürgen Rockstroh, University Hospital Bonn, Germany

The UK Epidemiology and Cascade
Valerie Delpech, Public Health England, United Kingdom

Prevention: Supporting Generic PrEP Access and Offering Monitoring – Legalities and Practicalities Efficiencies Viewed Through 90:90:90
Nneka Nwokolo, Chelsea and Westminster Hospital NHS Foundation Trust, United Kingdom

The England Experience: Commissioning and Prescribing Efficiencies
Laura Waters, Mortimer Market Centre, United Kingdom

The Patient’s Perspective
Angelina Namiba, Salamander Trust, United Kingdom

Panel Discussion